PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.\', \'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.\', \'Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA mark_heisem@med.unc.edu rbaric@email.unc.edu.\', \'Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.\', \'Rapidly Emerging Antiviral Drug Discovery Initiative, University of North Carolina, Chapel Hill, North Carolina, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e03149-2010.1128/mBio.03149-20
?:doi
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 33727353
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33727353>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33727353>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all